摘要
目的分析老年糖尿病患者用药依从性差的原因,并提出相应的对策,旨在控制血糖水平、延缓并发症发生。方法选取杭州市上城区湖滨街道社区卫生服务中心内分泌科收治的60岁以上的老年2型糖尿病患者113例。采用自制调查问卷对其依从性高低以及影响用药依从性的因素进行调查。结果依从性好的患者48例(42.48%),依从性差的患者65例(57.52%)。单因素分析结果显示:患者的文化程度的高低、月收入水平的多少、用药种类的多少、对糖尿病相关知识的了解程度以及是否独居和老年糖尿病患者用药依从性有关(P<0.05)。多因素Logistic回归分析结果显示,患者的文化程度低、月收入水平差、用药种类多以及独居是影响老年糖尿病患者用药依从性主要因素(P<0.05),且文化程度高低、月收入水平高低与糖尿病用药依从性呈正相关性,用药种类和独居与糖尿病用药依从性呈负相关性(P<0.05)。结论患者的文化程度低、月收入水平差、用药种类多以及独居是影响老年糖尿病患者用药依从性主要因素。通过社会、家庭的支持能够有效提高老年糖尿病患者用药的依从性。
Objective To analyze the causes of poor compliance of elderly patients with diabetes mellitus,and put forward corresponding countermeasures to control blood glucose level and delay the occurrence of complications. Methods A total of 113 elderly patients with type 2 diabetes mellitus aged 60 years and over were recruited in endocrinology department of our hospital. The self-made questionnaire was used to investigate the compliance and the factors that affected the compliance. Results There were 48 patients（ 42. 48%） with good compliance and 65 patients（ 57. 52%）with poor compliance. Univariate analysis showed that the level of education,monthly income,drug types,understanding of diabetes-related knowledge and whether the elderly living alone affected compliance（ P〈0. 05）. Multivariate Logistic regression analysis showed that patients with low education level,poor monthly income,medication types and living alone were the main factors that influence the compliance of elderly patients with diabetes mellitus（ P〈0. 05）. And the level of education,monthly income level and the compliance of diabetic medication was positively correlated,medication types and living alone and diabetes compliance were negatively correlated（ P〈0. 05）. Conclusion The low level of education,poor monthly income,medication types and living alone are the main factors that affect the compliance of elderly patients with diabetes. The social and family support can effectively improve the compliance of elder patients with diabetes.
出处
《中国生化药物杂志》
CAS
2016年第11期189-191,共3页
Chinese Journal of Biochemical Pharmaceutics
